New material contract exhibits, the moment they hit SEC EDGAR.

** **

Exhibit 10.1

** **

GENESIS MOREHOUSE AT 5580

LEASE

BP3-SD4 5580 MOREHOUSE DRIVE LLC,
a Delaware limited liability company,

** **

as Landlord,

** **

and

** **

CALIDI BIOTHERAPEUTICS, INC.,
a Delaware corporation,

** **

as Tenant

** **

** **

SUMMARY OF BASIC LEASE INFORMATION

This Summary of Basic Lease Information (“Summary”) is hereby incorporated into and made a part of the attached Lease. Each reference in the Lease to any term of this Summary shall have the meaning as set forth in this Summary for such term. In the event of a conflict between the terms of this Summary and the Lease, the terms of the Lease shall prevail. Any capitalized terms used herein and not otherwise defined herein shall have the meaning as set forth in the Lease.

…

LEASE TERMINATION AGREEMENT

This Lease Termination Agreement (this “Agreement”) is entered into as of this 10th day of July, 2026, by and between 4475 EXECUTIVE DRIVE LLC, a Delaware limited liability company (“Landlord”), and CALIDI BIOTHERAPEUTICS, INC., a Delaware corporation (“Tenant”).

r e c i t a l s:

A. Landlord and Tenant entered into that certain Lease dated as of October 10, 2022 (the “Original Lease”), as modified by that certain Confirmation of Lease Terms dated as of February 28, 2023, by and between Landlord and Tenant (the “Confirmation”), pursuant to which Landlord leased to Tenant, and Tenant leased from Landlord, certain space located on the 2nd floor (the “Premises”) in that certain building located at 4475 Executive Drive, San Diego, California (the “Building”). The Original Lease, as modified by the Confirmation, may be referred to herein as the “Lease”.

…

**EXECUTION VERSION **

FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT

THIS FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is made as of July 15, 2026 by and among DISTRIBUTION SOLUTIONS GROUP, INC., a Delaware corporation (formerly known as Lawson Products, Inc., the “Company”), each other Borrower under the Existing Credit Agreement, the other Loan Parties under the Existing Credit Agreement, the “Lenders” party to the Existing Credit Agreement (the “Existing Lenders”) signatory hereto, and JPMorgan Chase Bank, N.A., as the Administrative Agent (the “Administrative Agent”), under that certain Second Amended and Restated Credit Agreement, dated as of December 18, 2025, by and among the Company, the other Loan Parties party thereto, the financial institutions from time to time party thereto as Lenders and the Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Existing Credit Agreement”).

*RECITALS *

…

**EXECUTION VERSION **

***LIMITED GUARANTEE ***

This LIMITED GUARANTEE, dated as of July 15, 2026 (this “Limited Guarantee”), is made by LKCM Headwater Investments IV, L.P., a Delaware limited partnership** **(the “Guarantor”), in favor of Distribution Solutions Group, Inc., a Delaware corporation (the “Guaranteed Party”). Capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement (as defined below).

…

**EXECUTION VERSION **

**VOTING AND SUPPORT AGREEMENT **

This VOTING AND SUPPORT AGREEMENT (this “Agreement”) is made as of July 15, 2026 by and between Distribution Solutions Group, Inc., a Delaware corporation (the “Company”), and Luther King Capital Management Corporation, a Delaware corporation (the “Voting Party”).

WHEREAS, concurrently with the execution and delivery of this Agreement, the Company, Eclipse Parent Acquisitions, LLC, a Delaware limited liability company (“Parent”), Eclipse Intermediate Acquisitions, LLC, a Delaware limited liability company and a wholly owned Subsidiary of Parent (“Intermediate”), and Eclipse Acquisitions Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Intermediate (“Merger Sub”), have entered into an Agreement and Plan of Merger (as amended, restated, supplemented or otherwise modified from time to time in accordance with its terms, the “Merger Agreement”), pursuant to which, among other things, Merger Sub will be merged with and into the Company (the “Merger”), with the Company surviving the Merger a

…

---

Exhibit 10.1

Employment Agreement

This Employment Agreement (the "Agreement") is made and entered into by and between Sharath Cherian (the "Executive") and Destiny Media Technologies, Inc. (the "Company") (each a "Party" and collectively, the "Parties") and is effective as of July 15, 2026.

WHEREAS the Company desires to employ the Executive on the terms and conditions set forth herein; and

WHEREAS the Executive desires to be employed by the Company on such terms and conditions.

NOW, THEREFORE, in consideration of the mutual covenants, promises, and obligations set forth herein, the receipt and sufficiency of which is hereby acknowledged, Company and the Executive agree as follows:

1. Term. The Executive's start date will be July 15, 2026, or such other date as mutually agreed between the Executive and the Company in writing (the "Start Date"). 

2. Position and Duties.

…

** **

SECURITIES PURCHASE AGREEMENT

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of July 10, 2026, by and between Caring Brands, Inc., a Nevada corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser).

RECITALS

** **

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant an effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”), the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

…

** **

STOCK PURCHASE AGREEMENT

This STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of July 10, 2026 by and among Brian John, through his wholly-owned entity BK Investments LLC (the “Seller”) and the person or entity set forth as Purchaser on the signature page hereto (the “Purchaser”).

RECITALS

** **

WHEREAS, the Seller holds an aggregate o 150,000 shares of the common stock (the “Shares”) of Caring Brands, Inc. (the “Company”), a company listed on the Nasdaq Capital Market which trades under the symbol “CABR” that they desire to sell; and

WHEREAS, the Seller desires to sell 150,000 shares of the Common Stock (the “Shares”) to the Purchaser and Purchaser desires to purchase the Shares for an aggregate purchase price of $150,000 in cash (the “Purchase Price”).

NOW, THEREFORE, for and in consideration of the premises, the mutual agreements and covenants here in contained, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

AGREEMENT

…

** **

PERFORMANCE INCENTIVE BONUS AGREEMENT

THIS PERFORMANCE INCENTIVE BONUS AGREEMENT (this “Agreement”), dated July 15, 2026 (the “Effective Date”), is by and between TEN Holdings, Inc. (the “Company”), and Virgilio Torres (“Executive”).

WHEREAS, the Company’s Board of Directors (the “Board”) has approved an increased compensation package for Executive, effective upon the closing of the Company’s S-1 financing transaction;

WHEREAS, as previously approved by the Board, the Company desires to enter into this Agreement to incentivize Executive and to further align the Company performance goals with Executive’s compensation; and

WHEREAS, in consideration of the foregoing, the Company and Executive desire to enter this Agreement consist with the terms set forth herein.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and promises herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

…

**Employment Agreement **

This Employment Agreement is made by and between XTEND REALITY EXPANSION LTD., an Israeli company, registration number 515871861, with its offices at 7 Habarzel St., Tel Aviv (the “Company”), and Mor Swiel (the “Employee”).

The Employee has been employed by the Company since September 1st, 2025 (the “Commencement Date”) pursuant to the employment agreement signed on or about the same date (the “Prior Employment Agreement”), and the Company and the Employee wish to amend, restate and replace the Prior Employment Agreement in its entirety by entering into this Employment Agreement, effective as of the Effective Date (as such term defined below).

Below is a table summarizing the specific terms of Employee’s employment with the Company (the “Specific Terms”). The general terms and conditions of Employee’s employment with the Company are included in the pages following this table (the “General Terms”).

…

Private Placement Subscription Agreement

THE INTERESTS HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY OF THE INTERESTS DESCRIBED HEREIN.

THE PURCHASE OF THE INTERESTS INVOLVES A HIGH DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS OF THEIR ENTIRE INVESTMENT.

Bally’s Chicago, Inc.

640 N Lasalle, Suite 460

Chicago, IL 60654

Attention: Charles Diao, Chief Financial Officer

Ladies and Gentlemen:

The undersigned understands that Bally’s Chicago, Inc., a corporation organized under the laws of Delaware (the “Company”), is offering its Class A-4 Interests, Class A-5 Interests and Class A-6 Interests, each $0.001 par value per interest (each an “Interest” and collectively, the “Interests”) in a third-tranche private placement (the “Placement”).

…

WRITTEN CONSENT OF STOCKHOLDER

OF

BALLY’S CHICAGO, INC.

IN LIEU OF A MEETING

* * * * *

The undersigned, Bally’s Chicago Holding Company, LLC, a Delaware limited liability company (“HoldCo”), being a stockholder of Bally’s Chicago, Inc., a Delaware corporation (the “Corporation”), and the holder of shares of Class B common stock, par value $0.001 per share, of the Corporation (the “Class B Interests”), acting pursuant to Section 228 of the General Corporation Law of the State of Delaware (the “DGCL”) and Section 7.1 of the Corporation’s Second Amended and Restated Certificate of Incorporation (the “Existing Certificate”), does hereby execute this consent in lieu of a meeting of stockholders of the Corporation, without prior notice and without a vote, and does hereby consent to and adopt the following resolutions with the same force and effect as if adopted at a duly called and held meeting of the stockholders of the Corporation:

…

LLC INTERESTS SUBSCRIPTION AGREEMENT

THIS LLC INTERESTS SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into as of July 10, 2026, by and among Bally’s Chicago Operating Company, LLC, a Delaware limited liability company (the “Company”) and Bally’s Chicago, Inc., a Delaware corporation (the “Subscriber”). Capitalized terms used herein and not otherwise defined are used as defined in the Amended and Restated Limited Liability Company Agreement of the Company, dated as of March 10, 2025, as amended and/or restated from time to time (the “LLC Agreement”).

W I T N E S S E T H:

WHEREAS, the parties desire that the Subscriber subscribe for, and that the Company issue to the Subscriber, the number of LLC Interests set forth on Schedule A, on the terms and conditions hereinafter provided; and

WHEREAS, this Agreement is the LLC Subscription Agreement.

NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows:

…

Cannae Holdings, Inc.

1701 Village Center Circle

Las Vegas, NV 89134

July 15, 2026

Dear Bill:

On July 1, 2026, Cannae Holdings, Inc. (“Cannae”) issued a press release announcing that it has entered into an agreement with a company owned by you (“Foley”) to sell Cannae’s 87% interest in Brasada Ranch in exchange for the termination of Foley’s put right (the “Transaction”).    

As a closing condition of the Transaction, the Director Services Agreement dated May 12, 2025 between Cannae and Foley (the “Director Services Agreement”) shall be amended to terminate Foley’s put right.

On July 15, 2026, the Transaction closed. This letter agreement amends the Director Services Agreement.

By signing below the Company and Foley agree that the following Section 11(a) of the Director Services Agreement is deleted in its entirety:

…

Execution Version

REORGANIZATION AGREEMENT

** **

This Reorganization Agreement (this “Agreement”) is entered into as of July 13, 2026, by and among: (i) SPRINGBIG HOLDINGS, INC., a corporation organized and existing under the laws of the State of Delaware (the “Parent”); (ii) SPRINGBIG, INC., a corporation organized and existing under the laws of the State of Delaware (the “Company”); (iii) SHALCOR MANAGEMENT INC., a corporation organized and existing under the laws of the Province of Alberta, Canada (“Shalcor”), in its capacity as a Required Holder (as defined below) and as collateral agent and administrative agent for the Purchasers (as defined below) (in such capacity, “Agent”); LIGHTBANK II, L.P., a Delaware limited partnership (“Lightbank”) in its capacity as a Purchaser and Required Holder; and LS ROUND II, LLC, a limited liability company organized and existing under the laws of the State of Delaware (the “Transferee”). The Parent, the Company, Shalcor, Lightbank, and the Transferee are referred to herein individually as a “Party” and colle

…

GREEN CIRCLE DECARBONIZE TECHNOLOGY LIMITED

LOCK-UP AGREEMENT

July [●], 2026

Green Circle Decarbonize Technology Limited

Unit 1809, Prosperity Place, 6 Shing Yip St.

Kwun Tong, Kowloon, Hong Kong

Ladies and Gentlemen:

The undersigned understands that Green Circle Decarbonize Technology Limited, a Cayman Islands exempted company (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) on [●], 2026 with each purchaser (each, a “Purchaser”, and collectively “Purchasers”) identified on the signature page of the Securities Purchase Agreement, providing for the private placement (the “Transaction”) of convertible notes and warrants (“Warrants”) to purchase Ordinary Shares, US$0.001 par value per share, of the Company (“Shares”), and that in connection therewith, the Company expects to enter into a registration rights agreement with the Purchasers.

…

** **

PLACEMENT AGENT AGREEMENT

** **

July [●], 2026

PERSONAL AND CONFIDENTIAL

** **

Dr. Chan Kam Biu Richard, Chief Executive Officer

Green Circle Decarbonize Technology Limited

Unit 1809, Prosperity Place, 6 Shing Yip St.

Kwun Tong, Kowloon, Hong Kong

Re:	GCDT | PIPE Offering | Placement Agent Agreement

** **

Dear Dr. Richard:

…

EQUITY PURCHASE AGREEMENT

THIS EQUITY PURCHASE AGREEMENT (this “Agreement”) is entered into as of July [●], 2026 (the “Execution Date”), by and between Green Circle Decarbonize Technology Ltd, a Cayman Islands exempted company (the “Company”), and Target Capital 1, LLC, an Arizona limited liability company (the “Investor”).

RECITALS

WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company up to One Hundred Million U.S. Dollars (US$100,000,000.00) of the Company’s Ordinary Shares (as defined below);

NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Investor hereby agree as follows:

ARTICLE I

CERTAIN DEFINITIONS

…

ESCROW AGREEMENT

This ESCROW AGREEMENT (this “Agreement”) made as of July [●], 2026, by and among Green Circle Decarbonize Technology Ltd, (the “Issuer”), and Revere Securities LLC (the “Placement Agent”), whose addresses and other information appear on the Information Sheet (as defined herein) attached to this Agreement, and Continental Stock Transfer & Trust Company, 1 State Street, 30th Floor, New York, NY 10004 (the “Escrow Agent”).

WITNESSETH:

…

SECURITIES PURCHASE AGREEMENT

** **

This Securities Purchase Agreement (this “Agreement”) is dated as of July [●], 2026, between Green Circle Decarbonize Technology Limited, a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act, including Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

…

** **

REGISTRATION RIGHTS AGREEMENT

** **

This Registration Rights Agreement (this “Agreement”) is made and entered into as of July [●], 2026, between Green Circle Decarbonize Technology Limited, a Cayman Islands exempted company (the “Company”), and Target Capital 1, LLC (the “Purchaser”).

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and the Purchaser (the “Securities Purchase Agreement”).

The Company and the Purchaser hereby agree as follows:

…

QUMULUSAI, INC.

2026 EQUITY INCENTIVE PLAN

(Effective July 14, 2026)

---

Table of Contents

1.	Purpose of Plan.	1
2.	Definitions.	1
3.	Plan Administration.	6
4.	Shares Available for Issuance.	8
5.	Participation.	10
6.	Options.	10
7.	Stock Appreciation Rights.	12
8.	Restricted Stock Awards, Restricted Stock Units and Deferred Stock Units.	13
9.	Performance Awards.	14

…

Execution Version

AMENDMENT NO. 7 TO CREDIT AGREEMENT

This Amendment No. 7 to Credit Agreement (this “Amendment”), dated as of July 16, 2026 (the “Amendment Date”), is made by and among Movado Group, Inc., a New York corporation (“Parent”), Movado Group Delaware Holdings Corporation, a Delaware corporation (“MGDHC”), Movado LLC, a Delaware limited liability company (“MLLC”), Movado Retail Group, Inc., a New Jersey corporation (“MRGI”), MGI Luxury Group GmbH, a limited liability company organized and existing under the laws of Switzerland (“MGILG” and, together with Parent, MGDHC, MLLC, and MRGI, collectively, “Borrowers”), Movado Group Nederland B.V., a private company with limited liability incorporated under the laws of the Netherlands (“Nederland BV”, and, in its capacity as a guarantor, the “Guarantor” and, collectively with the Borrowers, the “Loan Parties”), the Lenders party hereto and Bank of America, N.A. (“BofA”), in its capacity as administrative agent (in such capacity, the “Administrative Agent”) under that certain Amended and Restat

…

** **

**[***] **

** **

Certain identified information has been excluded from this agreement, including all of the exhibits to this agreement, because it is both (i) not material and (ii) is the type of information the issuer both customarily and actually treats as private and confidential.

SERIES A INVESTMENT AGREEMENT

* *

among:

Maud Vinet

Mamato

Tristan

Meunier Triade

****(The Founders)

And:

CNRS Innovation

(The Minority Shareholders)

And:

FPCI Quantonation 1

FPCI Supernova Innovation 3

CEA Investissement

Casra Capital

(The Non-participating Existing Investors)

And:

Fonds Deep Tech 2030

FPCI Technocom 3

(The Participating Existing Investors)

* *

And: ****

** **

STMicroelectronics

ALIAD

SealSQ EIC Fund

[***]

TITANIA

(The New Investors)

In the presence of:

Quobly

(The Company)

Dated May 26, 2026

**[***] **

SERIES A INVESTMENT AGREEMENT

** **

AMONG:

** **

…

** **

The Class F shareholders

(as listed in Schedule 1 hereto)

and

WISeKey International Corp.

** **

(as the Company)

CLASS F shareholders’ agreement

Content

1	Definitions and Interpretation	1
** **	** **	** **
2	Class F Shares Voting Agreement	3
** **	** **	** **
3	Constitutional Documents	3
** **	** **	** **
4	Accession Deeds	3
** **	** **	** **

…

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. OMITTED INFORMATION HAS BEEN REPLACED WITH ASTERISKS.

AMENDMENT NO. 8

TO THE A320 FAMILY PURCHASE AGREEMENT

dated as of December 3, 2019

between

AIRBUS S.A.S.

and

UNITED AIRLINES, INC.

This Amendment No. 8 to the A320 Family Purchase Agreement between Airbus S.A.S. and United Airlines, Inc. (this “Amendment No. 8”), is entered into as of May 27, 2026 by and between Airbus S.A.S., a French société par actions simplifiée, organized and existing under the laws of France, having its registered office located at 2, rond-point Emile Dewoitine, 31700 Blagnac, France, registered with the Commercial and Companies Register of Toulouse under number 383 474 814 (the “Seller”), and United Airlines, Inc., a corporation organized and existing under the laws of the State of Delaware, United States of America, having its principal corporate offices located at 233 South Wacker Drive, Chicago, Illinois 60606 (the “Buyer”).

…

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. OMITTED INFORMATION HAS BEEN REPLACED WITH ASTERISKS.

SUPPLEMENTAL AGREEMENT NO. 16

to

PURCHASE AGREEMENT NUMBER 04815

between

THE BOEING COMPANY

and

UNITED AIRLINES, INC.

relating to

BOEING MODEL 787 AIRCRAFT

THIS SUPPLEMENTAL AGREEMENT No. 16 (SA-16) is entered into as of April 30, 2026 by and between The Boeing Company, a Delaware corporation, (Boeing) and United Airlines, Inc., a Delaware corporation, (Customer);

WHEREAS, Customer and Boeing entered into Purchase Agreement No. 04815 dated as of the 31st day of May of 2018 as amended and supplemented (Purchase Agreement), relating to the purchase and sale of Model 787 aircraft. This Supplemental Agreement is an amendment to the Purchase Agreement.

WHEREAS, the parties desire to provide clarity relative to the economic considerations applicable to *** 787-*** Aircraft.

…

DIRECTOR SERVICE AND INDEMNITY AGREEMENT

THIS DIRECTOR SERVICE AND INDEMNITY AGREEMENT (this “Agreement”) is entered into on July 15, 2026 (the “Effective Date”)

BY AND BETWEEN

AiRWA Inc., a corporation duly incorporated under the laws of the State of Delaware (the “Company”)

AND

Alejandro Quiles, an individual resident in the State of Nevada (the “Director”).

IN CONSIDERATION of the mutual covenants and agreements hereinafter contained and for other good and valuable consideration (the receipt and sufficiency of which is acknowledged by each party), the parties agree as follows:

SECTION 1: SERVICES, FEES, AND PAYMENT

1.1 The Company engages the Director as an independent contractor to provide the services described in Section A of Schedule A attached hereto (the “Services”), and the Director agrees to perform such Services.

…

** **

DIRECTOR SERVICE AND INDEMNITY AGREEMENT

THIS DIRECTOR SERVICE AND INDEMNITY AGREEMENT (this “Agreement”) is entered into on July 15, 2026 (the “Effective Date”)

BY AND BETWEEN

AiRWA Inc., a corporation duly incorporated under the laws of the State of Delaware (the “Company”)

AND

Guibao Ji (the “Director”).

IN CONSIDERATION of the mutual covenants and agreements hereinafter contained and for other good and valuable consideration (the receipt and sufficiency of which is acknowledged by each party), the parties agree as follows:

SECTION 1: SERVICES, FEES, AND PAYMENT

1.1 The Company engages the Director, currently an executive officer of the Company, to provide the services described in Section A of Schedule A attached hereto (the “Services”), and the Director agrees to perform such Services.

1.2 The Director agrees that he will not receive any compensation for his services as a Director beyond that received for his services as Chief Financial Officer of the Company.

…

CĪON Investment Corporation

8.00% Senior Unsecured Notes due 2031

Note Purchase Agreement

Dated July 15, 2026

Table of Contents

Section	Heading		PAGE
Section 1. Authorization of Notes; Interest Rate.			1

…

CĪON Investment Corporation

7.50% Senior Unsecured Notes due 2029

Note Purchase Agreement

Dated July 15, 2026

Table of Contents

Section		Heading	Page
Section 1. Authorization of Notes; Interest Rate.			1

…

---

Exhibit 10.1

AMENDMENT TO THE ENTERA BIO LTD. 2018 EQUITY INCENTIVE PLAN

This Amendment (the “Amendment”) to the 2018 Equity Incentive Plan (the “2018 Plan”) of Entera Bio Ltd., a company organized under the laws of the State of Israel (the “Company”), is made effective as of July 14, 2026. Unless otherwise specifically defined herein, each capitalized term used herein shall have the meaning afforded such term under the 2018 Plan.

WHEREAS, the Board of Directors of the Company (the “Board”) via meeting of the Board held on May 7, 2026, determined it to be in the best interests of the Company to amend the 2018 Plan to increase the aggregate number of ordinary shares, par value NIS 0.0000769 per share (“Ordinary Shares”) of the Company authorized for issuance thereunder by a one-time additional amount of 2,500,000 Ordinary Shares (the “Share Increase”); and

WHEREAS, at the Company’s 2026 annual meeting of shareholders held on July 14, 2026, the Company’s shareholders approved the Share Increase.

…

NAI-5012918200v5

EXHIBIT 10.1

EXECUTION VERSION

SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

THIS SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”) is entered into as of July 15, 2026, by and among CrossAmerica Partners LP, a Delaware limited partnership (the “Partnership”), Lehigh Gas Wholesale Services, Inc., a Delaware corporation (“Services” and, together with the Partnership, the “Borrowers”), the Guarantors (as defined below) party hereto, each of the Lenders and L/C Issuers party hereto and Citizens Bank, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”) and as Collateral Agent (in such capacity, the “Collateral Agent”).

W I T N E S S E T H:

…

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT

THIS SECOND AMENDMENT to Loan and Security Agreement (this “Amendment”) is entered into as of July 15, 2026, by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 115 South Union Street, Suite 300, Alexandria, VA 22314 (“Oxford”), as collateral agent (in such capacity, “Collateral Agent”), the Lenders listed on Schedule 1.1 of the Loan Agreement (as defined herein) or otherwise a party to the Loan Agreement from time to time, including Oxford in its capacity as a Lender, OXFORD FINANCE CREDIT FUND II LP, by its manager Oxford Finance Advisors, LLC, with an office located at 115 South Union Street, Suite 300, Alexandria, VA 22314 and OXFORD FINANCE CREDIT FUND III LP, by its manager Oxford Finance Advisors, LLC, with an office located at 115 South Union Street, Suite 300, Alexandria, VA 22314 (each a “Lender” and collectively, the “Lenders”), and INHIBRX BIOSCIENCES, INC., a Delaware corporation with an office located at 11025 North Torrey Pines Road, Suite 140, La Jolla, CA 92037 (“Borrower”).

…

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of _____, 2026, is made and entered into by and among Phalanx Acquisition Corp I, a Cayman Islands exempted company (the “Company”), Phalanx Acquisition Sponsor I LLC, a Delaware limited liability company (the “Sponsor”) and Cantor Fitzgerald & Co. and Odeon Capital Group LLC (collectively, the “IPO Underwriters” and together with the Sponsor, the “Purchasers”) (the Sponsor and the IPO Underwriters together with any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).

RECITALS

WHEREAS, the Company has 5,031,250 Class B ordinary shares, par value $0.0001 per share (the “Founder Shares”), issued and outstanding, up to 656,250 of which will be surrendered to the Company for no consideration depending on the extent to which the underwriters of the Company’s initial public offering exercise their over-allotment option;

…

PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT

This PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (this “Agreement”) is made as of the _______ day of ____, 2026, by and between Phalanx Acquisition Corp I, a Cayman Islands exempted company (the “Company”), Cantor Fitzgerald & Co. and Odeon Capital Group LLC (individually as the “Subscriber” and collectively as the “Subscribers”).

WHEREAS, the Company desires to sell to the Subscribers on a private placement basis (the “Offering”) an aggregate of 2,400,000 warrants (including to the extent that the over-allotment option in connection with the Company’s initial public offering is exercised) (each, a “Placement Warrant” and, collectively, the “Placement Warrants”) of the Company, for a purchase price of $1.00 per Placement Warrant. The Class A Ordinary Shares (as defined below) underlying the Warrants are hereinafter referred to as the “Warrant Shares”. The Placement Warrants and Warrant Shares, collectively, are hereinafter referred to as the “Securities.” Each whole Placement Warrant

…

**Exhibit 10.8 **

** **

PHALANX ACQUISITION CORP I

VIG Tower – Penthouse

1225 Avenida Juan Ponce De Leon

San Juan, Puerto Rico 00907

August 28, 2025

Phalanx Acquisition Corp I

VIG Tower – Penthouse

1225 Avenida Juan Ponce De Leon

San Juan, Puerto Rico 00907

** **

	RE:	Securities Subscription Agreement

Ladies and Gentlemen:

…

** **

PHALANX ACQUISITION CORP I

VIG Tower – Penthouse

1225 Avenida Juan Ponce De Leon

San Juan, Puerto Rico 00907

[_], 2026

Phalanx Sponsor Management I LLC

VIG Tower – Penthouse

1225 Avenida Juan Ponce De Leon

San Juan, Puerto Rico 00907

Re:	Administrative Services Agreement

Ladies and Gentlemen:

This letter agreement by and between Phalanx Acquisition Corp I (the “Company”) and Phalanx Sponsor Management I LLC (the “Services Provider”), the managing member of Phalanx Acquisition Sponsor I LLC (the “Sponsor”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are first listed on the Nasdaq Global Market (the “Listing Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination and t

…

** **

__________, 2026

	Re:	Forward Purchase Contract

Ladies and Gentlemen:

We are pleased to accept the offer Celeres PIPE Opportunities I LLC (the “Subscriber” or “you”) has made to purchase up to an aggregate of $25,000,000 of securities of Phalanx Acquisition Corp I, a Cayman Islands exempted company (the “Company”), in connection with the Company’s initial Business Combination (as defined below). The securities to be purchased pursuant hereto are hereinafter collectively referred to as the “Securities.” The Company and the Subscriber’s agreements regarding such Securities are set forth in this agreement (this “Agreement”) and are as follows:

…

[●], 2026

Phalanx Acquisition Corp I
VIG Tower – Penthouse

1225 Avenida Juan Ponce De Leon

San Juan, Puerto Rico 00907

Re:	Initial Public Offering

Ladies and Gentlemen:

This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Phalanx Acquisition Corp I, a Cayman Islands exempted company (the “Company”) and Cantor Fitzgerald & Co. as representative (the “Representative”) of the underwriters (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”), of up to 20,125,000 of the Company’s units (including up to 2,625,000 units which may be purchased to cover over-allotments, if any) (the “Units”), each comprised of one Class A ordinary share, par value $0.0001 per share, of the Company (the “Class A Ordinary Shares”) and one-half of one redeemable warrant (each whole warrant, a “Warrant”). Each Warrant

…

** **

**INVESTMENT MANAGEMENT TRUST AGREEMENT **

This Investment Management Trust Agreement (this “Agreement”) is made effective as of _____, 2026 by and between Phalanx Acquisition Corp I, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).

WHEREAS, the Company’s registration statement on Form S-1, (File No. 333-[ ]) (the “Registration Statement”) and prospectus (the “Prospectus”) for the initial public offering of the Company’s units (the “Units”), each of which consists of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Ordinary Share (such initial public offering hereinafter referred to as the “Offering”), has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission;

…

PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT

THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of _____, 2026 (as it may from time to time be amended, this “Agreement”), is entered into by and between Phalanx Acquisition Corp I, a Cayman Islands exempted company (the “Company”), and Phalanx Acquisition Sponsor I LLC, a Delaware limited liability company (the “Purchaser”).

WHEREAS, the Company intends to consummate an initial public offering of the Company’s units (the “Public Offering”), each unit consisting of one Class A Ordinary Share, par value $0.0001 per share, of the Company (an “Ordinary Share”), and one-half of one redeemable warrant. Each whole warrant entitles the holder to purchase one Ordinary Share at an exercise price of $11.50 per Ordinary Share. The Purchaser has agreed to purchase an aggregate of 3,750,000 warrants (whether or not the over-allotment option in connection with the Public Offering is exercised in full) (the “Private Placement Warrants”), each Private Placement Warrant entitling the holder to pu

…

FORM OF INDEMNITY AGREEMENT

THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [_], 2026, by and between Phalanx Acquisition Corp I, a Cayman Islands exempted company (the “Company”), and the undersigned (“Indemnitee”).

RECITALS

WHEREAS, highly competent persons have become more reluctant to serve publicly-held companies as directors, officers or in other capacities unless they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of such companies;

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its Subsidiaries (as defined below) from certain liabilities;

…

** **

PHALANX ACQUISITION CORP I

1225 Avenida Juan Ponce De Leon

San Juan, Puerto Rico 00907

[_], 2026

Phalanx Sponsor Management I LLC

VIG Tower – Penthouse

1225 Avenida Juan Ponce De Leon

San Juan, Puerto Rico 00907

Re: Advisory Services and Indemnification Agreement

Ladies and Gentlemen:

This advisory services and indemnification agreement (this “Agreement”) is being entered into by and among Phalanx Acquisition Corp I (the “Company”) and Phalanx Sponsor Management I LLC (the “Sponsor Affiliate”), dated as of the date hereof, to confirm our agreement that:

…

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.  

** **

AMENDED AND RESTATED PROMISSORY NOTE

Principal Amount: Up to $500,000	Dated as of March 31, 2026 New York, New York

Preliminary Statement

This amended and restated promissory note (this “Note”) amends and restates the promissory of Maker to Payee (in each case, as defined below) dated December 31, 2025 (the “Original Note”) to increase the aggregate principal amount and extend the maturity date. The Original Note is hereby null and void.

***

…

SETTLEMENT AND PATENT LICENSE AGREEMENT

VPR Brands, LP | R.J. Reynolds Vapor Company

U.S. Patent No. 8,205,622 B2

* *

This SETTLEMENT AND PATENT LICENSE AGREEMENT (the “Agreement”) is made and entered into and is effective as of July 10, 2026, (the “Effective Date”) by and between VPR Brands, LP, a limited partnership organized under the laws of the State of Delaware, having a place of business at 1141 Sawgrass Corporate Parkway, Sunrise, Florida 33323 (“Licensor” or “VPR”), and R.J. Reynolds Vapor Company, a corporation organized under the laws of the State of North Carolina, having a place of business at 401 North Main Street, Winston-Salem, North Carolina 27101 (“Licensee” or “RJR”). Licensor and Licensee are each individually referred to as a “Party,” and collectively as the “Parties.”

RECITALS

** **

WHEREAS, Licensor is the owner of all right, title, and interest in and to, including the right to sue for past, present, and future infringement of, U.S. Patent No. 8,205,622 B2;

…

INDEMNIFICATION AGREEMENT

This Indemnification Agreement (this “Agreement”) is entered into as of July 1, 2026 by and between U Power Ltd, a Cayman Islands company (the “Company”), and the undersigned, a director and/or an officer of the Company (“Indemnitee”), as applicable.

RECITALS

The board of directors of the Company (the “Board of Directors”) has determined that the inability to attract and retain highly competent persons to serve the Company is detrimental to the best interests of the Company and its shareholders and that it is reasonable and necessary for the Company to provide adequate protection to such persons against risks of claims and actions against them arising out of their services to the Company.

AGREEMENT

** **

In consideration of the premises and the covenants contained herein and subject to the Company’s memorandum and articles of association, as may be amended from time to time, the Company and Indemnitee do hereby covenant and agree as follows:

A. DEFINITIONS

The following terms shall have the meanings defined below:

…

Independent Director Appointment Agreement

This Agreement is executed by the following two parties on July 1, 2026:

Party A: U Power Limited

Address: McGrath Tonner Corporate Services Limited, Genesis Building, 5th Floor Floor, Genesis Close,PO Box 446,Cayman Islands,KY1-1106

Party B: Lü Bo

ID Number: 420104197812253312

Address: Room 902, Building 5, Modern Jingyuan, Gongshu District, Hangzhou

In this Agreement, each of the aforementioned parties is referred to as “one party” individually, and collectively as “both parties”.

in view of ：

…

Certain information in this document has been omitted and replaced with “[***]”. Such identified information has been omitted from this document because it is not material and is of the type that the registrant treats as private or confidential.

EFFECTIVE JULY 10, 2026

David R. Vetter

16202 Bay Vista Drive

Clearwater, Florida 33760

Re: Updated terms and conditions of employment

Dear David:

TD SYNNEX Corporation (the “Company”) is pleased to offer you updated terms and conditions of employment pursuant to this employment agreement (the “Agreement”) related to your position of Chief Legal Officer of the Company on the following terms effective as of July 10, 2026 (the “Effective Date”):

1.Terms of Employment.

…

Zoomcar Holdings, Inc.

Website: www.zoomcar.com

May 11, 2026

ACM Zoomcar Convert LLC

c/o Atalaya Capital Management LP

One Rockefeller Plaza, 32nd Floor,

New York, NY 10020

	Re:	Letter of Understanding

** **

Dear Drew,

This letter (the “Letter”) captures the agreement between Zoomcar Holdings, Inc. (“Zoomcar”) and ACM Zoomcar Convert LLC (“ACM”) regarding the path forward to resolve the outstanding judgments entered against Zoomcar on July 1, 2025 (“ACM Judgment”) and reflects the parties’ intention to proceed and resolve such matters as per the terms below.

…

Execution Version

REVOLVING CREDIT, GUARANTY

AND

SECURITY AGREEMENT

AMONG

RESOURCES CONNECTION, INC.

RESOURCES CONNECTION LLC

AND

EACH PERSON JOINED HERETO FROM TIME TO TIME AS A BORROWER

AS BORROWERS,

VERACITY CONSULTING GROUP, LLC

REFERENCE POINT LLC

AND

EACH PERSON JOINED HERETO FROM TIME TO TIME AS A GUARANTOR

AS GUARANTORS,

EACH FINANCIAL INSTITUTION PARTY HERETO FROM TIME TO TIME AS A LENDER

AND

PNC BANK, NATIONAL ASSOCIATION

AS AGENT

JULY 15, 2026

    1

---

LIST OF EXHIBITS AND SCHEDULES

Exhibits

Exhibit 1.2        Borrowing Base Certificate

Exhibit 1.2(a)        Compliance Certificate

Exhibit 2.1(a)         Revolving Credit Note

Exhibit 2.4(a)        Swing Loan Note

Exhibit 5.5(b)        Financial Projections

Exhibit 8.1(g)        Financial Condition Certificate

Exhibit 17.3         Commitment Transfer Supplement

Exhibit 3.10(e)(iii)        Form of U.S. Tax Compliance Certificate

Exhibit 3.10(e)(iv)(1)        Form of U.S. Tax Compliance Certificate

Exhibit 3.10(e)(iv)(2)        Form of U.S. Tax Compliance Certificate

…

HEALTHLYNKED CORPORATION

** **

Interim Chief Financial Officer Consulting Engagement Letter

** **

Date: July 10, 2026

** **

Mr. George O’Leary

Dear George,

HealthLynked Corporation (“HealthLynked” or the “Company”) is pleased to offer you the opportunity to serve as the Company’s Interim Chief Financial Officer during one of the most important periods in the Company’s history.

The purpose of this engagement is to provide executive financial leadership necessary to successfully complete the Company’s uplisting to the Nasdaq Capital Market, strengthen the Company’s financial infrastructure, and assist management in positioning HealthLynked for its next phase of growth and capital formation.

** **

Position

You will serve as Interim Chief Financial Officer of HealthLynked Corporation, reporting directly to the Chief Executive Officer and working closely with the Board of Directors.

…

CONFIDENTIAL

Karthik Gopalakrishnan

Vega Links Inc.

Chief Executive Officer

313 Bryant Court

Palo Alto, CA 94301

Re: Binding Letter of Intent for Acquisition of VEGA LINKS, Inc.

Dear Karthik,

This binding letter of intent (this “Letter”), together with the term sheet attached hereto, sets forth our mutual understanding regarding the terms of an acquisition of Vega Links Inc. and its affiliate(s) (collectively “VLI”) by Palomino Laboratories Inc. (“PLI”) in a transaction structured as an acquisition of all of the issued and outstanding shares of capital stock of VLI by PLI (the “Acquisition”). It is understood that any such transaction includes our mutual agreement on terms, and the entering into by VLI and PLI (each, a “Party” and collectively, the “Parties”) of definitive documents for the Acquisition and neither Party shall have any obligations other than as explicitly set forth herein unless and until a definitive agreement is entered into by and between VLI and PLI.

…

CYBER ENVIRO-TECH INC

** **

2026 OMNIBUS INCENTIVE COMPENSATION PLAN

** **

1. Purpose of the Plan.

This CETI 2026 Omnibus Incentive Compensation Plan has two complementary purposes: (i) to attract and retain outstanding individuals to serve as officers, directors, employees, and consultants and (ii) to increase shareholder value. The Plan will provide participants with incentives to increase shareholder value by offering the opportunity to acquire shares of the Company’s common stock, receive monetary payments based on the value of such common stock, or receive other incentive compensation, on the potentially favorable terms that this Plan provides.

2. Definitions.

As used in the Plan or in any instrument governing the terms of any Award, the following definitions apply to the terms indicated below:

(a) “Affiliate” means the Company and any of its direct or indirect Subsidiaries.

…

NON-BINDING LETfER OF INTENT

Date: July 3, 2026

To: Bio-Path Holdings, Inc.

Attn: Vik Grover

From: Farrington Capital Group LLC. and/or its designated affiliate, VantioBio and or Vantio Alpha Fund

Bio-Path Holdings, Inc. ("Bio-Path") and Farrington Capital Group LLC. and/or its designated affiliate, VantioBio and or Vantio Alpha Fund (collectively,"Buyer") are pleased to outline the principal terms of a proposed strategic transaction. This Letter of Intent is intended to provide a framework for diligence and negotiation concerning an exclusive out-license, asset acquisition, or similar transaction involving the DNAbilize platform and related Bio-Path programs, studies, data, know-how, intellectual property, regulatory materials, manufacturing information, and development documentation.

Transaction Scope

The contemplated transaction would include some or all of the following, to the extent owned, controlled, or licensable by Bio-Path:

•          Prexigebersen (BP1001), including related AML studies and supporting materials.

…

LETTER OF INTENT – PARTNERSHIP AND INVESTMENT BIO-PATH HOLDINGS, INC. – ALTFINS, J. S. A.

** **

Executive Summary

** **

Bio-Path Holdings, Inc. (OTC: BPTH) and altFINS are exploring a strategic partnership whereby BPTH establishes a Gen2 digital asset treasury - moving beyond passive Bitcoin accumulation toward a multi-asset, systematically managed cryptocurrency portfolio informed by altFINS’ institutional-grade on-chain fundamentals and technical analysis.

This proposal outlines the partnership structure, a phased treasury deployment plan, the specific altFINS capabilities BPTH would leverage, and how BPTH can differentiate itself from first-generation treasury adopters.

Metric	Value
Public companies holding crypto (mid-2026)	~200+
Collective holdings at peak	$180BN

Market Context: Gen1 vs. Gen2 Treasury Strategies

…

---

Exhibit 10.1

EXECUTION VERSION

AMENDMENT NO. 7 TO MASTER FRAMEWORK AGREEMENT

This AMENDMENT NO. 7 TO MASTER FRAMEWORK AGREEMENT (this “Amendment”), is made and entered into as of July 10, 2026 (the “Amendment Date”), by and among each of:

(A)

MUFG Bank, Ltd., a Japanese banking corporation (“MUFG”), as buyer (“Buyer”);

(B)

TXU Energy Retail Company LLC, a Texas limited liability company (“TXU”), as seller (the “Seller”);

(C)

each originator party hereto (each, an “Originator”; and together with the Seller, each a “Seller Party” and collectively, the “Seller Parties”);

(D)

TXU, as agent for the Seller Parties (in such capacity, the “Seller Party Agent”); and

(E)

solely with respect to Section 4.4 hereof, Vistra Operations Company LLC, as guarantor (the “Guarantor”),

…

***Execution Version ***

TERM LOAN CREDIT AGREEMENT

dated as of

July 15, 2026

Among

BAKER HUGHES HOLDINGS LLC,

as the Borrower,

BAKER HUGHES COMPANY,

as the Parent Guarantor,

The Lenders Party Hereto,

and

BANK OF AMERICA, N.A., as Administrative Agent

$1,000,000,000 TERM LOAN CREDIT FACILITY

BOFA SECURITIES, INC.,

as sole Bookrunner and sole Lead Arranger

---

**TABLE OF CONTENTS **

| | | | | | | | | ------------------------------------------ | - | ------------------------------------------------- | : | :--: | -: | - | | | | | | | | | | | | | | Page | | | | ARTICLE I DEFINITIONS | | | | | 1 | |

…

***Execution Version ***

TERM LOAN CREDIT AGREEMENT

dated as of

July 15, 2026

Among

BAKER HUGHES HOLDINGS LLC,

as the Borrower,

BAKER HUGHES COMPANY,

as the Parent Guarantor,

The Lenders Party Hereto,

and

UNICREDIT BANK GMBH, NEW YORK BRANCH, as Administrative Agent

$1,000,000,000 TERM LOAN CREDIT FACILITY

UNICREDIT BANK GMBH, NEW YORK BRANCH, as sole Bookrunner and sole Lead Arranger

---

**TABLE OF CONTENTS **

| | | | | | | | | ------------------------------------------ | - | ------------------------------------------------- | : | :--: | -: | - | | | | | | | | | | | | | | Page | | | | | | | | | | |

…

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of July 14, 2026, between Cardiff Oncology, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

DEFINITIONS

1.1

…

​

​

​

Exhibit 10.1

SEPARATION** **AGREEMENT

This Separation Agreement (this “Agreement”) is entered into by and between Glenn Reicin (“Executive”) andHarmony Biosciences Holdings,Inc. and Harmony Biosciences Management, Inc. (together the “Company”), effective as of July 16, 2026 (the “Effective Date”).

1.Separation.Effective as of July 16, 2026(the “Separation Date”), Executive’s employment with the Company and all of its affiliates shall terminate and Executive shall cease to be an employee of all of the foregoing. The parties hereto acknowledgeandagree that, effectiveas of the Separation Date, (i) thatcertain Employment Agreement, datedas of April 14, 2026,byandbetweenExecutiveandtheCompany(the“Employment Agreement”)shallterminate(exceptasotherwiseexpresslysetforthhereinandtherein)andtheCompany shall have no further obligations under the Employment Agreement; and (ii) Executive shall be deemed to have resigned from all offices and directorships held with the Company and its subsidiaries.

2.Separation* from Employment*.

…

SETTLEMENT AGREEMENT

This SETTLEMENT AGREEMENT (this “Agreement”) is entered into as of this 15th day of July, 2026 (the “Effective Date”), by and between Sadot Group Inc., a Nevada corporation (the “Company”), and Helena Global Investment Opportunities I Ltd., a Cayman Islands exempted company (the “Holder”). The Company and the Holder are each a “Party” and collectively the “Parties.”

RECITALS

…

** **

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED BY MEANS OF MARKING SUCH PORTIONS WITH BRACKETS (“[***]”) BECAUSE THE IDENTIFIED CONFIDENTIAL PORTIONS (I) ARE NOT MATERIAL AND (II) FORUM MARKETS, INCORPORATED CUSTOMARILY AND ACTUALLY TREATS THAT INFORMATION AS PRIVATE OR CONFIDENTIAL.

ENGINE SALE AND PURCHASE AGREEMENT

Dated as of July 13, 2026

BETWEEN

AERO ENGINE SOLUTIONS, INC.

as Seller

and

EURUS AEROSPACE TOKEN I LLC

as Buyer

with respect to the sale and purchase of one (1) CFM International model CFM56-7B aircraft engine bearing manufacturer’s serial number [***]

ENGINE SALE AND PURCHASE AGREEMENT

**THIS ENGINE SALE AND PURCHASE AGREEMENT **(this “Agreement”) is dated as of this 13th day of July 2026 and entered into by and between:

…

July 15, 2026

Lindsay Androski
Via E-mail

Re: Special Bonus Awards

Dear Lindsay:

Arbutus Biopharma, Inc. (together with Arbutus Biopharma Corporation, “Arbutus”) is writing to inform you of your eligibility to receive the following special cash bonus awards on the terms and conditions set forth in this letter agreement (this “Agreement”). Each of the payments described in the first three paragraphs of this Agreement is subject to the terms and conditions set forth in the fourth, fifth and sixth paragraphs of this Agreement.

…

TERMINATION AGREEMENT

** **

This TERMINATION AGREEMENT (this “Termination Agreement”) is entered into as of July 15, 2026 (the “Termination Agreement Effective Date”), by and between Arbutus Biopharma Corporation, a British Columbia corporation (“Arbutus”), and Genevant Sciences GmbH, a limited liability company organized and existing under the laws of Switzerland (“Genevant”). Arbutus and Genevant may be referred to herein individually as a “Party” and together as the “Parties.”

RECITALS

WHEREAS, the Parties entered into that certain Agreement, dated as of March 2, 2025 (the “mRESVIA Agreement”), regarding the treatment of any recovery from Moderna, Inc. and its affiliates (together, “Moderna”) in the Parties’ patent infringement litigation against Moderna (as described more fully in the mRESVIA Agreement, the “Patent Litigation”) specifically allocated to Moderna’s vaccine marketed as mRESVIA®;

…

---

Exhibit 10.1

Execution Version

VOTING AND SUPPORT AGREEMENT

THIS VOTING AND SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of July 15, 2026, by and between Eli Lilly and Company, an Indiana corporation (“Parent”), and the undersigned holder (the “Stockholder”) of common stock, par value $0.01 per share, of AtaiBeckley Inc., a Delaware corporation (the “Company”, and such shares of common stock, the “Company Shares”). Capitalized terms used herein and not defined shall have the meanings ascribed to them in the Agreement and Plan of Merger, dated as of July 15, 2026 by and among Parent, Albali Acquisition Corporation, a Delaware corporation and an indirect wholly owned Subsidiary of Parent (“Merger Sub”), and the Company (the “Merger Agreement”).

…

** **

New Horizon Aircraft ltd.

** **

Employee Stock purchase Plan

** **

Adopted by the Board of Directors Effective: May 1, 2024

** **

Approved by the Stockholders: effective May, 1 2024

** **

I. PURPOSE

The Employee Stock Ownership Plan (“ESPP”) provides a means by which Eligible Employees of the Company may acquire shares of Common Stock. The Plan provides that the Company will match Eligible Employees procurement of Common Shares of the Company under an Employee Stock Purchase Plan, up to a defined maximum amount.

The Company, by means of the Plan, seeks to retain the services of Eligible Employees, to secure and retain the services of new Employees, and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Affiliates.

** **

II. Administration

The Board has responsibility for administering the Plan. By delegation of the Board, the Company’s Compensation Committee may administer the Plan.

…

Exhibit 10(b)

    May 5, 2026 Equity Grant Agreement

GE Aerospace 2022 Long-Term Incentive Plan

GE Aerospace Restricted Stock Unit Grant Agreement (“Grant Agreement”)

For <<Insert Name>>

Grant Date							RSUs Granted	Vesting Date

…

Exhibit 10(a)

GE AEROSPACE 2022 LONG-TERM INCENTIVE PLAN
Amended and restated as of May 5, 2026

Section I.Purpose

The purpose of this GE Aerospace 2022 Long-Term Incentive Plan is to attract, retain and motivate current and prospective employees, officers, non-employee directors and other service providers of the Company. Stock- and performance-based compensation provided under this Plan is designed to align such individuals’ interests and efforts with those of the Company’s shareholders.

Section II.Definitions

As used in the Plan, the following terms shall have the meanings set forth below:

(a)“Act” means the Securities Exchange Act of 1934.

(b)“Affiliate” means any company or business entity under the direct or indirect control of the Company, and any company or business entity in which the Company has a 50% or more interest, in each case, as determined by the Committee.

…

Certain identified information has been excluded from this exhibit both because it (i) is not material and (ii) is the type that the issuer treats as private or confidential. Brackets with triple asterisks denote omissions.

BRIDGE CREDIT AGREEMENT

Dated as of July 16, 2026

among

UBER TECHNOLOGIES, INC.,
as the Borrower,

MORGAN STANLEY SENIOR FUNDING, INC.,
as Administrative Agent,

and

The Other Lenders Party Hereto

MORGAN STANLEY SENIOR FUNDING, INC.,
BofA SECURITIES, INC. and
DEUTSCHE BANK SECURITIES INC.,
as
Joint Lead Arrangers and Joint Bookrunners

BofA SECURITIES, INC. and
DEUTSCHE BANK SECURITIES INC.
as Syndication Agents

TABLE OF CONTENTS

…

** **

LOCK-UP AGREEMENT

May 21, 2026

HCW Biologics Inc.

2929 N. Commerce Parkway

Miramar, FL 33025

Re: Placement Agency Agreement, dated as of May 21, 2026 (the “Placement Agency Agreement”), between HCW Biologics Inc. (the “Company”) and E.F. Hutton & Co. (the “Placement Agent”).

Ladies and Gentlemen:

Defined terms not otherwise defined in this letter agreement (the “Letter Agreement”) shall have the meanings set forth in the Placement Agency Agreement. In satisfaction of a condition of the Company’s obligations under the Placement Agreement, the undersigned irrevocably agrees with the Company that, from the date hereof until one hundred eighty (180) days after the Closing Period (such period, the “Restriction Period”), the undersigned will not offer, sell, contract to sell, hypothecate, pledge or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the undersigned or any Affiliat

…

**FORM OF **

SECURITIES EXCHANGE AGREEMENT

This Securities Exchange Agreement** **(this “Agreement”), dated as of July 15, 2026 (the “Effective Date”), is entered into by and between ASP Isotopes Inc., a Delaware corporation (the “Company”), Quantum Leap Energy LLC, a Delaware limited liability company (“QLE”), and the person or entity identified on the signature page hereto (the “Holder”).

RECITALS

WHEREAS, the Company, QLE and the Holder are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), or Rule 506(b) of Regulation D (“Regulation D”) promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act;

…

FORM of Support AGREEMENT

This SUPPORT AGREEMENT (this “Agreement”) is made as of July 10, 2026, by and among INTERNATIONAL STEM CELL CORPORATION, a Delaware corporation (“Parent”), Lifeline Cell Technologies, LLC, California limited liability company (“Target”), AMERICAN TYPE CELL COLLECTION, INC., a District of Columbia corporation (“Purchaser”), and the Person set forth on Schedule A hereto ( “Stockholder”).

…

MEMBERSHIP INTEREST PURCHASE AGREEMENT

by and among

RON G. SCOTT, an individual and

PROGRESSIVE CARE, LLC, a Nevada Limited Liability Company

dated as of July 14, 2026

Exhibits

Exhibit A          Form of Noncompetition Agreement

Exhibit B          Form of Assignment of Membership Interests

Exhibit C          Form of Powers of Attorney

Exhibit D          Disclosure Schedules

MEMBERSHIP INTEREST PURCHASE AGREEMENT

THIS MEMBERSHIP INTEREST PURCHASE AGREEMENT (this “Agreement”) is entered into as of the 14th day of July, 2026 (the “Effective Date”) by and among PROGRESSIVE CARE, LLC, a Nevada limited liability company (the “Purchaser”), and RON G. SCOTT, an individual (the “Seller”) for the purchase of 100% of the membership interests in SCOTT’S PHARMACY, LLC, a Florida limited liability company (the "Company") (Purchaser and Seller are from time to time referred to individually as a “Party” and collectively as the “Parties”) as follows:

Background Statement

…

* *

SUBSCRIPTION AGREEMENT

THIS SUBSCRIPTION AGREEMENT (the “Agreement”) is dated as of July 9, 2026 by and between KSY Capital Investments, Inc of registered address 701 Karns Ct, North Wales, PA 19454 (the “Purchaser”), and Global AI, Inc. a Nevada corporation of registered address 110 Front Street, Suite 300, Jupiter, Florida 33477, (“Issuer). The Purchaser and Issuer, may hereinafter be referred to as the “Parties” and each, a “Party.”

WHEREAS, the Purchaser desires to subscribe for 250,000 shares of the Issuer’s Class A Common Stock, $0.001 (the “Shares”) from the Issuer, and Issuer desires to issue the Shares to the Purchaser in exchange for a purchase price of $2.00 per Share for a total purchase price of One Million One Hundred Thousand United States Dollars (USD $500,000.00) (the “Purchase Price”).

…

---

GAMESQUARE HOLDINGS, INC.

** **

OPTION AGREEMENT

This Option Agreement is entered into between GameSquare Holdings, Inc. (the “Company”) and the Optionee named below pursuant to the Incentive Plan of the Company (as may be amended or superseded, the “Plan”), and confirms that:

1. on **July 10, 2026 **(the “Grant Date”);

2. Justin Kenna (the “Optionee”);

3. was granted the option to purchase 1,195,712 common shares (the “Optioned Shares”) of the Company;

4. for the price of US$0.31 per Optioned Share (the “Exercise Price”);

5. exercisable from time to time after vesting up to, but not after, July 9, 2031; and

6. the Optioned Shares shall vest, on the terms and subject to the conditions set out in the Plan, on the following schedule:

	●	803,570 on the Grant Date

	●	392,142 on July 10, 2027

** **

…

---

** **

---

** **

Restricted Share Unit Grant

GameSquare Holdings, Inc.

** **

Grantee: Amaree Vichairattanawong

We are pleased to provide you with confirmation of a grant of restricted stock units (“RSUs”) under the GameSquare Holdings, Inc. (“GameSquare”) Incentive Plan (the “Incentive Plan”) in connection with your service to GameSquare as follows:

Restricted Share Unit Terms

Restricted Stock:	You have been granted 50,000 RSUs of GameSquare.
Grant Date:	July 10, 2026
Vesting Schedule:	The RSUs granted herein shall become vested as of the Grant Date.

…

GAMESQUARE HOLDINGS, INC.

** **

OPTION AGREEMENT

This Option Agreement is entered into between GameSquare Holdings, Inc. (the “Company”) and the Optionee named below pursuant to the Incentive Plan of the Company (as may be amended or superseded, the “Plan”), and confirms that:

1. on **July 10, 2026 **(the “Grant Date”);

2. Mike Munoz (the “Optionee”);

3. was granted the option to purchase 301,249 common shares (the “Optioned Shares”) of the Company;

4. for the price of US$0.31 per Optioned Share (the “Exercise Price”);

5. exercisable from time to time after vesting up to, but not after, July 9, 2031; and

6. the Optioned Shares shall vest, on the terms and subject to the conditions set out in the Plan, on the following schedule:

	●	188,280 on the Grant Date

	●	112,969 on July 10, 2027

** **

…

Certain information marked as [***] has been excluded from this exhibit because it is
both not material and is the type that the registrant treats as private or confidential.

EXCLUSIVE LICENSE AGREEMENT

This EXCLUSIVE LICENSE AGREEMENT becomes effective as of 21st day of December, 2021 (the “Effective Date”) by and between Kissei Pharmaceutical Co., Ltd., a corporation duly organized and existing under the laws of Japan and having its registered office at 19-48, Yoshino, Matsumoto-City, Nagano- Prefecture, Japan (“Kissei”) and Vogenx, Inc., a corporation duly organized and existing under the laws of North Carolina, and having its principal place of business at 3200 East Hwy 54, Suite 100, Research Triangle Park, NC 27709 United States (“Vogenx”). Each of Kissei and Vogenx is referred to herein as a “Party” and collectively, as the “Parties.”

WITNESSETH THAT:

…

Vogenx, Inc. 2022 Equity Incentive Plan

1. Purpose; Eligibility.

1.1 General Purpose. The name of this plan is the Vogenx, Inc. 2022 Equity Incentive Plan (the “Plan”). The purposes of the Plan are to (a) enable Vogenx, Inc., a Delaware corporation (the “Company”), to attract and retain the types of Employees, Consultants and Directors who will contribute to the Company’s long range success; (b) provide incentives that align the interests of Employees, Consultants and Directors with those of the shareholders of the Company; and (c) promote the success of the Company’s business.

1.2 Eligible Award Recipients. The persons eligible to receive Awards are the Employees, Consultants and Directors of the Company and its Affiliates.

1.3 Available Awards. Awards that may be granted under the Plan include: (a) Incentive Stock Options, (b) Non-Qualified Stock Options, (c) Restricted Stock and (d) Restricted Stock Units.

2. Definitions.

…

LAMB WESTON HOLDINGS, INC. 2026 INDUCEMENT STOCK PLAN (as Amended and Restated as of July 13, 2026) SECTION 1. NAME AND PURPOSE 1.1 Name. The name of the plan shall be the Lamb Weston Holdings, Inc. 2026 Inducement Stock Plan (the “Plan”). 1.2 Purpose of Plan. The purpose of the Plan is to provide awards as an inducement material to certain employees of the Company who are entering into employment with the Company or any of its Subsidiaries and to encourage stock ownership by such individuals, thereby aligning their interests with those of the Company’s stockholders. This Plan is intended to comply with Rule 303A.08 of the New York Stock Exchange Listed Company Manual, which provides an exception to the New York Stock Exchange’s shareholder approval requirement for the issuance of securities with respect to grants to employees of the Company as an inducement material to such individuals entering into employment with the Company, and shall be administered and interpreted consistent with such intent. SECTION 2. DEFINITIONS 2.1 Definitions. Whenever used herein, the following terms shal

…

RESALE ORGANIZATION AGREEMENT

This Resale Organization Agreement (this “Agreement”) is entered into as of April 14, 2026, by and among Stereotaxis, Inc., a Delaware corporation (the “Purchaser”), and the sellers listed on Exhibit A hereto (each, a “Seller,” and collectively, the “Sellers”).

RECITALS

WHEREAS, Purchaser and the Sellers have entered into that certain Share Sale Agreement, dated as of April 14, 2026 (the “SPA”), pursuant to which Purchaser has agreed to issue to the Sellers shares of Purchaser Common Stock and Purchaser Warrants as consideration for the acquisition of their securities of Robocath S.A.;

WHEREAS, pursuant to Section 2.2(a)(v) of the SPA, the parties have agreed to enter into this Agreement to govern the orderly resale of Registrable Securities following the Closing;

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

ARTICLE I — DEFINITIONS

…

** **

Exhibit 10.5

** **

REGISTRATION RIGHTS AGREEMENT

** **

This Registration Rights Agreement (this “Agreement”) is entered into effective as of July 14, 2026 (the “Execution Date”), by and between Glucotrack, Inc., a Delaware corporation (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”).

RECITALS

** **

A. WHEREAS, in connection with the Common Stock Purchase Agreement, dated as of July 14, 2026, by and between the Company and the Investor (the “Purchase Agreement”), the Company may issue and sell to the Investor, from time to time, and the Investor shall purchase from the Company, up to $50,000,000 in aggregate gross purchase price of newly issued Purchase Notice Shares;

B. WHEREAS, in consideration for the Investor’s execution and delivery of the Purchase Agreement, the Company shall issue to the Investor the Commitment Shares and the Commitment Warrant (each as defined in the Purchase Agreement),

…

** **

Exhibit 10.1

** **

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of July 14, 2026, by and between Glucotrack, Inc., a corporation incorporated under the laws of the State of Delaware (the “Company”), and the investors named on the signature pages annexed hereto (collectively, the “Investors”).

BACKGROUND

A. The board of directors (the “Board of Directors”) of the Company has authorized the issuance to the Investors of certain Notes (as defined below) and Warrants (as defined below).

B The Investor desires to purchase the Note on the terms and conditions set forth in this Agreement.

NOW THEREFORE, in consideration of the foregoing recitals and the covenants and agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:

…

VOTING SUPPORT AGREEMENT

THIS VOTING SUPPORT AGREEMENT, dated as of July __, 2026 (this “Agreement”), is entered into by and among the investors listed on the signature page hereto (collectivity, the “Investor”), and each of the individuals or entities listed on the signature pages hereto (each, a “Stockholder” and, together, the “Stockholders”).

RECITALS

**A. **Concurrently with the execution and delivery of this Agreement, Glucotrack, Inc., a corporation incorporated under the laws of the State of Delaware (the “Company”), is entering into that certain Securities Purchase Agreement, dated as of July 14, 2026, by and among the Company and the Investor (the “Purchase Agreement”), pursuant to which the Company will issue and sell to the Investor senior secured convertible promissory notes (collectively, the “Note”) and warrants to purchase shares of Common Stock (as defined in the Purchase Agreement) of the Company (the “Warrants”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Purchase Agreement.

…

** **

Exhibit 10.4

** **

COMMON STOCK PURCHASE AGREEMENT

** **

This Common Stock Purchase Agreement (this “Agreement”) is dated as of July 14, 2026 (the “Effective Date”), by and between Glucotrack, Inc., a Delaware corporation (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”).

WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall purchase, from time to time, as provided herein, and the Company shall issue and sell up to Fifty Million Dollars ($50,000,000) of the Company’s Common Stock (as defined below);

…

SECURITY AGREEMENT

This SECURITY AGREEMENT, dated as of July 14, 2026 (this “Agreement”), is among Glucotrack, Inc., a Delaware corporation (the “Company” or the “Debtor”), White Lion Capital LLC, a Delaware limited liability company, as collateral agent for the Secured Parties (in such capacity, the “Collateral Agent”), and the investors named herein, (collectively with their respective endorsees, transferees and assigns, the “Secured Parties”).

W I T N E S S E T H:

WHEREAS, pursuant to the securities purchase agreement entered into by the Company and the Secured Parties on or around July 14, 2026 (the “Purchase Agreement”), the Secured Parties have agreed to extend the loan to Company as evidenced by those certain senior secured convertible promissory notes dated on or around July 14, 2026, in the original aggregate principal amount of up to $5,705,128.10 (collectively, the “Note”);

…

**Exhibit 10.34 **

**AVENZO THERAPEUTICS, INC. **

August 22, 2022

Mohammad Hirmand, M.D.

[***]

Re:	**Employment Terms **

Dear Mohammad:

Avenzo Therapeutics, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Executive Vice President and Chief Medical Officer on the terms and conditions set forth in this letter agreement (the “Agreement”).

…

**Exhibit 10.33 **

**AVENZO THERAPEUTICS, INC. **

August 22, 2025

Athena M. Countouriotis, M.D.

[***]

Re:	**Employment Terms **

Dear Athena:

This letter agreement (the “Agreement”) is effective as of August 22, 2025 (the “Effective Date”) and amends and restates that certain letter agreement between you and Avenzo Therapeutics, Inc. (the “Company”) dated August 18, 2022 (the “Prior Agreement”). The terms of this Agreement supersede the terms of the Prior Agreement in their entirety.

…

**Exhibit 10.38 **

**CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE AVENZO THERAPEUTICS, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO AVENZO THERAPEUTICS, INC. IF PUBLICLY DISCLOSED. **

**AMENDMENT NO.1 TO COLLABORATION, EXCLUSIVE OPTION AND LICENSE AGREEMENT **

This AMENDMENT NO.1 TO COLLABORATION, EXCLUSIVE OPTION AND LICENSE AGREEMENT (this “Amendment”) is entered into as of November 26, 2024 (the “Amendment Effective Date”) by and between Avenzo Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (“Avenzo”), with offices located at 12707 High Bluff Drive, Suite 200, San Diego, California 92130, United States, and VelaVigo (Shanghai) Limited, a corporation organized and existing under the laws of China (“VelaVigo”), with offices located at Building 1, 215 Fute South Rd, WGQ Free Trade Zone, Pudong, Shanghai, and for purposes of Sections 5.8 and 5.9, Article 18 and Article 19 of the License Agreeme

…

**Exhibit 10.35 **

**AVENZO THERAPEUTICS, INC. **

August 22, 2022

Brian Sun

[***]

Re:	**Employment Terms **

Dear Brian:

Avenzo Therapeutics, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Senior Vice President, Chief Legal Officer and Corporate Secretary on the terms and conditions set forth in this letter agreement (the “Agreement”).

…

**Exhibit 10.39 **

**CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE AVENZO THERAPEUTICS, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO AVENZO THERAPEUTICS, INC. IF PUBLICLY DISCLOSED. **

**COLLABORATION AND LICENSE AGREEMENT **

**by and between **

AVENZO THERAPEUTICS, INC.

**and **

**DUALITY BIOLOGICS (SUZHOU) CO., LTD. **

**dated as of December 23, 2024 **

---

**TABLE OF CONTENTS **

…

**Exhibit 10.36 **

**CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE AVENZO THERAPEUTICS, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO AVENZO THERAPEUTICS, INC. IF PUBLICLY DISCLOSED. **

**COLLABORATION AND LICENSE AGREEMENT **

**by and between **

AVENZO THERAPEUTICS, INC.

**and **

ALLORION THERAPEUTICS INC.

**dated as of January 3, 2024 **

---

**TABLE OF CONTENTS **

…

**Exhibit 10.32 **

**AVENZO THERAPEUTICS, INC. **

**COMMON STOCK PURCHASE AGREEMENT **

This Common Stock Purchase Agreement (the “Agreement”) is made as of [  ] by and between Avenzo Therapeutics, Inc., a Delaware corporation (the “Company”) and [  ] (“Purchaser”). Certain capitalized terms used below are defined in the terms and conditions set forth in Exhibit A attached to this Agreement, which are incorporated by reference.

…

**Exhibit 10.37 **

**CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE AVENZO THERAPEUTICS, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO AVENZO THERAPEUTICS, INC. IF PUBLICLY DISCLOSED. **

**COLLABORATION, EXCLUSIVE OPTION AND LICENSE AGREEMENT **

**by and between **

AVENZO THERAPEUTICS, INC.

**and **

**VELAVIGO (SHANGHAI) LIMITED **

**and **

**for purposes of Sections 5.8 and 5.9 and Articles 18 and 19, **

**VELAVIGO BIO, INC. **

**dated as of November 16, 2024 **

---

**TABLE OF CONTENTS **

…

**Exhibit 10.41 **

***FIRST AMENDMENT TO OFFICE LEASE ***

This FIRST AMENDMENT TO OFFICE LEASE (this “First Amendment”) is made and entered into as of December 6, 2024, by and between KR JUNCTION, LLC, a Delaware limited liability company (“Landlord”), and AVENZO THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

R E C I T A L S :

A. Landlord (as successor-in-interest to BRE CA OFFICE OWNER LLC, a Delaware limited liability company) and Tenant entered into that certain Office Lease dated 11/7/2022 (the “Lease”), whereby Landlord leases to Tenant and Tenant leases from Landlord those certain premises consisting of 17,223 rentable square feet (collectively, the “Existing Premises”) comprised of: (i) that certain space consisting of 5,960 rentable square feet of space commonly known as Suite 250 (“Suite 250”) and located on the second (2nd) floor of that certain building (the “Building”) located at 12707 High Bluff Drive, San Diego, California 92130, and (ii) that certain space consisting of 11,263 rentable square feet of space com

…

**Exhibit 10.40 **

***OFFICE LEASE ***

11/7/2022

This Office Lease (this “Lease”) is dated November ___, 2022, by and between BRE CA OFFICE OWNER LLC, a Delaware limited liability company (“Landlord”) and AVENZO THERAPEUTICS, INC., a Delaware corporation (“Tenant”). The following exhibits are incorporated herein and made a part hereof: Exhibit A-1 (Outline of Suite 250, Suite 200, and Potential Offering Space [Suite 225]); Exhibit A-2 (Outline of Temporary Space); ***Exhibit ***B (Expenses and Taxes); Exhibit C-1 (Suite 250 Tenant Work Letter); Exhibit C-2 (Suite 200 Tenant Work Letter); ***Exhibit ***D (Form of Confirmation Letter); ***Exhibit ***E (Rules and Regulations); ***Exhibit ***F (Additional Provisions); ***Exhibit ***G (Judicial Reference); Exhibit H (Form of Letter of Credit); Exhibit I (Approximate Location of Signage).

**1 BASIC LEASE INFORMATION. **

1.1 Premises.

…